Lataa...
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis
Statins are a class of drugs that inhibit 3-hydroxy-3-methylglutaryl-coenzyme A (HMGcoA) reductase, a critical enzyme in the mevalonate pathway. Several reports document that statins may prevent different human cancers. However, whether or not statins can prevent cancer is controversial due to disco...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1988916/ https://ncbi.nlm.nih.gov/pubmed/17622571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-09-048033 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|